However, to our knowledge, there has been no study on the relative expression and cellular location of all members of the HER family, EGFRvIII, and putative cancer stem cell biomarkers (e.g., CD44, CD109) and their prognostic significance when expressed alone or in combination in patients with brain tumours. The gene discussed is CD44; the disease is cancer.